Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Landman

Showing results (41-50 of 49) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 49 results.
Plos One|May 16, 2014
Genetic signature of histiocytic sarcoma revealed by a sleeping beauty transposon genetic screen in miceRaha A Been, Michael A Linden, Courtney J Hager, et al.
HIV Medicine|April 6, 2005
Comparison of gastrointestinal tolerability and patient preference for treatment with the 625 mg and 250 mg nelfinavir tablet formulationsM Johnson, L Nieto-Cisneros, A Horban, et al.
Journal of Clinical Pharmacology|May 24, 2011
The effect of CYP3A4 inhibition or induction on the pharmacokinetics and pharmacodynamics of orally administered ruxolitinib (INCB018424 phosphate) in healthy volunteersJack G Shi, Xuejun Chen, Thomas Emm, et al.
HIV Clinical Trials|February 3, 2006
Early virologic failure and rescue therapy of tenofovir, abacavir, and lamivudine for initial treatment of HIV-1 infection: TONUS studyR Landman, D Descamps, G Peytavin, et al.
Bioorganic & Medicinal Chemistry|April 28, 2016
Synergistic reduction of HIV-1 infectivity by 5-azacytidine and inhibitors of ribonucleotide reductaseJonathan M O Rawson, Megan E Roth, Jiashu Xie, et al.
Antimicrobial Agents and Chemotherapy|May 5, 2010
Gag mutations can impact virological response to dual-boosted protease inhibitor combinations in antiretroviral-naïve HIV-infected patientsLucile Larrouy, C Chazallon, R Landman, et al.
Molecular Cancer Research : MCR|May 22, 2015
Transposon Mutagenesis Screen Identifies Potential Lung Cancer Drivers and CUL3 as a Tumor SuppressorCasey Dorr, Callie Janik, Madison Weg, et al.
Nature Communications|November 30, 2016
Truncation and constitutive activation of the androgen receptor by diverse genomic rearrangements in prostate cancerChristine Henzler, Yingming Li, Rendong Yang, et al.
Stroke|June 7, 2021
Detection of Atrial Fibrillation After Central Retinal Artery OcclusionBrian Mac Grory, Sean R Landman, Paul D Ziegler, et al.
Pageof 5

Showing results (41-50 of 49) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 49 results.
Plos One|May 16, 2014
Genetic signature of histiocytic sarcoma revealed by a sleeping beauty transposon genetic screen in miceRaha A Been, Michael A Linden, Courtney J Hager, et al.
HIV Medicine|April 6, 2005
Comparison of gastrointestinal tolerability and patient preference for treatment with the 625 mg and 250 mg nelfinavir tablet formulationsM Johnson, L Nieto-Cisneros, A Horban, et al.
Journal of Clinical Pharmacology|May 24, 2011
The effect of CYP3A4 inhibition or induction on the pharmacokinetics and pharmacodynamics of orally administered ruxolitinib (INCB018424 phosphate) in healthy volunteersJack G Shi, Xuejun Chen, Thomas Emm, et al.
HIV Clinical Trials|February 3, 2006
Early virologic failure and rescue therapy of tenofovir, abacavir, and lamivudine for initial treatment of HIV-1 infection: TONUS studyR Landman, D Descamps, G Peytavin, et al.
Bioorganic & Medicinal Chemistry|April 28, 2016
Synergistic reduction of HIV-1 infectivity by 5-azacytidine and inhibitors of ribonucleotide reductaseJonathan M O Rawson, Megan E Roth, Jiashu Xie, et al.
Antimicrobial Agents and Chemotherapy|May 5, 2010
Gag mutations can impact virological response to dual-boosted protease inhibitor combinations in antiretroviral-naïve HIV-infected patientsLucile Larrouy, C Chazallon, R Landman, et al.
Molecular Cancer Research : MCR|May 22, 2015
Transposon Mutagenesis Screen Identifies Potential Lung Cancer Drivers and CUL3 as a Tumor SuppressorCasey Dorr, Callie Janik, Madison Weg, et al.
Nature Communications|November 30, 2016
Truncation and constitutive activation of the androgen receptor by diverse genomic rearrangements in prostate cancerChristine Henzler, Yingming Li, Rendong Yang, et al.
Stroke|June 7, 2021
Detection of Atrial Fibrillation After Central Retinal Artery OcclusionBrian Mac Grory, Sean R Landman, Paul D Ziegler, et al.
Pageof 5